Micar Innovation (Micar21), is one of the world’s companies in the AI-based Drug Discovery Market (2nd Edition) - Roots Analysis

AI-based Drug Discovery Market (2nd Edition): Distribution by Drug Discovery Steps (Target Identification / Validation, Hit Generation / Lead Identification, Lead Optimization), Therapeutic Area (Oncological Disorders, CNS Disorders, Infectious Diseases, Respiratory Disorders, Cardiovascular Disorders, Endocrine Disorders, Gastrointestinal Disorders, Musculoskeletal Disorders, Immunological Disorders, Dermatological Disorders and Others) and Key Geographies (North America, Europe, Asia-Pacific, Latin America, MENA, and RoW): Industry Trends and Global Forecasts, 2022-2035

Micar Innovation (Micar21), is one of the world’s 198 companies in the report alongside corporations such as AbbVie, Merck, etc.

The good news is that the world renowned market analysis agency Roots Analysis published a study on the main players in “In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules (Antibodies, Proteins, Peptides, Nucleic Acid, Gene Therapy and Vectors), 2020-2030 (Including Structure Based Drug Discovery, Fragment Based Drug Discovery, Ligand Based Drug Discovery, Target Based Drug Discovery, Interface Based Drug Discovery Approaches)”. Our company, Micar Innovation, is one of the world’s 198 companies in the report alongside corporations such as Sanofi, Merck, etc.

Micar Innovation (Micar21) is one of the world’s 130 companies, listed in Deep Knowledge Analytics report: AI for Drug Discovery and Advanced R&D Landscape / 2018 Q4, Q3 and Q2.

AI for Drug Discovery Landscape Overview Q4/2018 / AI for Drug Discovery Landscape Overview Q3/2018 / AI for Drug Discovery Landscape Overview Q2/2018 / AI for Drug Discovery Landscape Overview 2017

Micar Innovation (Micar21), is one of the world’s 250 companies in the report alongside corporations such as Sanofi, Merck, etc.

The good news is that the world renowned market analysis agency Roots Analysis published a study on the main players in “Computer-Aided Drug Discovery Services Market 2018-2030”. Our company, Micar Innovation, is one of the world’s 250 companies in the report alongside corporations such as Sanofi, Merck, etc.

Computer-Aided Drug Discovery Services Market, 2018-2030

Micar Innovation (Micar21) - BioPharmaTrend.com is a market and industry analytics platform for investors, analysts, researchers and business leaders, helping them get knowledgable insights into emerging technologies and trends in pharmaceutical R&D.

A Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D // A Map of AI Startups in Drug Discovery // https://www.biopharmatrend.com/m/company/micar-innovation/ // About BiopharmaTrend.com BioPharmaTrend.com is a market and industry analytics platform for investors, analysts, researchers and business leaders, helping them get knowledgable insights into emerging technologies and trends in pharmaceutical R&D. Focus areas include: Artificial Intelligence (AI) for drug discovery / development R&D outsourcing trends in (bio)pharmaceutical industry Digital transformation of pharma R&D industry (cloud / API-services / ecommerce / mobile tech trends / cheminformatics / bioinformatics) Drug discovery trends (medicinal chemistry / screening technologies etc) Small molecules vs. biologics BioPharmaTrend.com also hosts articles contributed by top industry professionals and thought leaders, including researchers / top-managers and business leaders.

Startups Using Artificial Intelligence in Drug Discovery: Who is who in 10 words

Micar 21 Uses AI to: Shorten discovery and screening, lead optimization, and ADMET studies. Allows researchers to: Create "build-to-buy" partnerships, forming startups around new drug discovery programs that pharmaceutical companies can then acquire if successful.

The Bulgarian IT Ecosystem: Who is who in 10 words

Micar 21 — provide drug discovery in short time — using in silico and Artificial Intelligence